PLVAP and Cognitive impairment: Endothelial specific inactivation of β-catenin in vivo BBB has been reported to cause significant downregulation of CLDN3, upregulation of plasmalemma vesicle-associated protein, and BBB breakdown, which leads to cognitive disorders, including Alzheimer’s disease (AD) [49].